Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Estrogen Receptor
83%
Breast Cancer
76%
Breast Cancer Cells
34%
Inflammatory Breast Cancer
29%
Estrogen Receptor β
27%
Apoptosis
24%
Estrogen
22%
Estrogen Signaling
21%
Epithelial-to-mesenchymal Transition
21%
B-cell Lymphoma 2 (Bcl-2)
21%
Luminal Breast Cancer
20%
Tumor Cells
19%
Clinical Outcomes
18%
Metastasis
18%
Induced Apoptosis
17%
Unfolded Protein Response
17%
Notch Signaling
17%
Breast Tumor
16%
Prolactin
16%
N-acetylcysteine
16%
Human Breast Cancer Cells
16%
C-Jun
16%
Nitric Oxide Synthase Inhibition
16%
Metaplastic Breast Carcinoma
16%
DLL1
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Endocrine Resistance
16%
Programmed Death Ligand
16%
Endoplasmic Reticulum Stress (ER stress)
14%
Cancer Cells
14%
Sigma Phase
14%
Tumor
13%
Breast Tumorigenesis
12%
Chemosensitivity
12%
In Cancer
11%
DNA Damage Response
11%
NF-B
11%
Estrogen Receptor 1 (ESR1)
11%
Cell Cycle Arrest
10%
Cell Cycle Progression
10%
Therapeutic Approaches
10%
Estrogen Receptor Signaling
10%
Subtype-specific
10%
Jurkat Cells
10%
Phosphoinositide 3-kinase (PI3K)
10%
MCF-7
10%
Actin
10%
Cdc25
10%
Non-small Cell Lung Cancer Cells
10%
Cancer Cell Survival
10%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
95%
Cancer Cell
88%
Programmed Cell Death
46%
P53
36%
Carcinogenesis
28%
Tumor Progression
26%
Endoplasmic Reticulum Stress
24%
Mesenchymal-Epithelial Transition
23%
Nitric Oxide Synthase
22%
Notch Signaling Pathway
20%
Estrogen Receptor Beta
18%
Mouse Model
17%
Epidermal Growth Factor Receptor
16%
Tumor-Associated Macrophage
16%
Unfolded Protein Response
15%
Cancer Stem Cell
15%
Cell Survival
14%
S Phase
14%
Cell Migration
13%
Actin
13%
Chemosensitivity
12%
Bcl-2
12%
DNA Damage Response
12%
Downregulation
11%
Phosphoinositide 3-Kinase
11%
Drug Resistance
11%
Cell Cycle Arrest
10%
Cell Cycle Checkpoint
10%
Phosphotransferase
10%
Kinase
10%
Wild Type
9%
Upregulation
9%
Biological Functions
9%
Metastasis Inhibition
9%
Potassium Channel
8%
Progesterone Receptor
8%
2-Methoxyestradiol
8%
Cell Cycle Progression
8%
Phosphatase
8%
X Box Binding Protein 1
8%
Vitamin C
8%
Subcellular Localization
8%
Ferroptosis
8%
Leukemia Inhibitory Factor
8%
Leukemia Inhibitory Factor Receptor
8%
Ascorbic Acid
8%
Radiosensitivity
8%
Fibroblast
8%
DNA Damage
8%
Inositol
8%
Medicine and Dentistry
Breast Cancer
100%
Estrogen Receptor
54%
Neoplasm
28%
Cancer Cell
23%
Receptor
19%
Metastatic Carcinoma
19%
Protein P53
19%
Tumor Cell
18%
Inflammatory Breast Cancer
18%
Tumor
17%
Nitric Oxide Synthase
16%
Macrophage
16%
Carcinogenesis
13%
Tumor Microenvironment
13%
Cancer Stem Cell
12%
Mesenchymal-Epithelial Transition
11%
Immunosuppressive Drug
11%
Notch Signaling
11%
Chemosensitivity
11%
Phosphoinositide 3-Kinase
10%
Drug Resistance
10%
Tamoxifen
9%
Alpelisib
9%
Hormone Therapy
9%
Estrogen Receptor Beta
9%
DNA Damage Response
8%
N(g) Methylarginine
8%
Breast Tumor
8%
Radiosensitivity
8%
Cancer Associated Fibroblast
8%
Cell Migration
8%
Actin
8%
Somatics
8%
Unfolded Protein Response
8%
Ionizing Radiation
8%
Micronucleus
8%
Non Small Cell Lung Cancer
8%
Ferroptosis
8%
Leukemia Inhibitory Factor Receptor
8%
Leukemia Inhibitory Factor
8%
Nitric Oxide
8%
Vimentin
8%
Ovarian Cancer
8%
Cell Cycle Checkpoint
7%
Inducible Nitric Oxide Synthase
6%
Radiation Therapy
6%
Tumor Progression
5%
Combination Therapy
5%
Xenograft
5%
